Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy

Background. Parkinson's disease (PD) remains a clinical diagnosis and biomarkers are needed to detect the disease as early as possible. Genetically determined PD provides an opportunity for studying metabolic differences in connection with disease development. Objectives. To study the levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Aasly, Jan O., Sæther, Oddbjørn, Johansen, Krisztina K., Bathen, Tone F., Giskeødegård, Guro F., White, Linda R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556333/
https://www.ncbi.nlm.nih.gov/pubmed/26357583
http://dx.doi.org/10.1155/2015/264896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556333/
https://www.ncbi.nlm.nih.gov/pubmed/26357583
http://dx.doi.org/10.1155/2015/264896

Ejemplares similares